NEW YORK (GenomeWeb News) - Columbia University said yesterday that it has licensed a pathogen-detection technology called MassTag PCR to Indian contract research and testing organization Vimta Labs.

Vimta will use the technology to develop clinical diagnostic products for patients in India, the university's technology transfer arm, Columbia Science and Technology Ventures, said in a statement.

MassTags are small chemical compounds of different molecular weights that are added to nucleotide primer sequences by an ultraviolet photocleaver linker, the STV said.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Researchers describe a way to share data while keeping it secure, Agence France Presse reports.

In Science this week: genetic mutations typically associated with esophageal cancer are common in older, healthy individuals, and more.

India's Council of Scientific and Industrial Research has a new director-general, according to ScienceInsider.

A new study links more than a hundred genes to autism spectrum disorder, Discover's D-brief blog reports.